Marshall Wace’s MediciNova MNOV Stock Holding History

Marshall Wace’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-110,200	Closed	-$295K	–	3750
2021 Q4	$295K	Sell	110,200 -174,502	-61%	-$583K	﹤0.01%	3041
2021 Q3	$1.08M	Sell	284,702 -188,254	-40%	-$715K	﹤0.01%	1971
2021 Q2	$2.01M	Buy	+472,956	New	+$2.04M	0.01%	1407
2020 Q2	–	Sell	-12,748	Closed	-$47K	–	1811
2020 Q1	$47K	Sell	12,748 -8,344	-40%	-$43.4K	﹤0.01%	1443
2019 Q4	$142K	Buy	+21,092	New	+$159K	﹤0.01%	1405
2019 Q2	–	Sell	-6,526	Closed	-$54K	–	1653
2019 Q1	$54K	Buy	+6,526	New	+$56.9K	﹤0.01%	1520

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's MNOV Position: Q1 2022 in Review

Marshall Wace sold out of MediciNova (MNOV) in Q1 2022, closing a stake of 110,200 shares — an estimated $295K sold.

Marshall Wace first reported a position in MNOV in Q1 2019 and held it in 6 quarters. The position peaked at $2.01M in Q2 2021. 32 funds tracked by Wall St. Rank hold MNOV as of Q1 2022.

Marshall Wace reported no remaining MediciNova position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 110,200 MediciNova shares in Q1 2022, an estimated $295K.
Marshall Wace first reported a position in MediciNova in Q1 2019 and held it in 6 quarters.
Marshall Wace's MediciNova position peaked at $2.01M in Q2 2021.
32 funds tracked by Wall St. Rank held MediciNova as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.